Semaglutide (Wegovy) first weight management medication in the world to show reduction in cardiovascular events
NEW ON DRSUE.CA! Prefer to listen? Check out my audio recording of this post here: After...
Read Moreby Dr. Sue Pedersen | Nov 12, 2023 | Media, Research | 0
NEW ON DRSUE.CA! Prefer to listen? Check out my audio recording of this post here: After...
Read Moreby Dr. Sue Pedersen | Nov 9, 2023 | Diabetes, Research, Uncategorized | 0
NEW ON DRSUE.CA! Prefer to listen? Check out my audio recording of this post here: It is...
Read Moreby Dr. Sue Pedersen | Aug 28, 2023 | Research, Uncategorized | 0
Heart failure is a known health complication that can occur in people with elevated weight. As...
Read Moreby Dr. Sue Pedersen | Aug 9, 2023 | Media, Research, Uncategorized | 0
People who carry excess body weight have an increased risk of cardiovascular disease. Thus, one...
Read Moreby Dr. Sue Pedersen | Jul 14, 2023 | Research, Uncategorized | 0
As blogged previously, existing data suggests that GLP1 receptor agonists (GLP1RAs) may protect...
Read Moreby Dr. Sue Pedersen | Jun 29, 2023 | Diabetes, Media, Research, Uncategorized | 0
This year’s American Diabetes Association (ADA) meeting has concluded, leaving...
Read Moreby Dr. Sue Pedersen | Jun 26, 2023 | Diabetes, Media, Research, Uncategorized | 0
At a symposium yesterday at the American Diabetes Association meeting, I was delighted and honored...
Read Moreby Dr. Sue Pedersen | Jun 17, 2023 | Research, Uncategorized | 0
I was recently asked to give lectures on emerging obesity medications at a symposium at...
Read Moreby Dr. Sue Pedersen | Apr 13, 2023 | Research, Uncategorized | 0
Obesity is a risk factor for over 200 health conditions, and included on this list is...
Read Moreby Dr. Sue Pedersen | Sep 10, 2022 | Research, Uncategorized | 0
In discussing weight management medication in my practice, two of the most common questions I get...
Read Moreby Dr. Sue Pedersen | Jul 22, 2022 | Bariatrics, Research, Uncategorized | 0
While bariatric surgery is a very effective treatment of obesity for many people, some people...
Read Moreby Dr. Sue Pedersen | Jun 29, 2022 | Bariatrics, Research, Uncategorized | 0
We know that obesity is associated with an increased risk of many types of cancer (including...
Read MoreI am a medical doctor, Specialist in Endocrinology & Metabolism, and a Diplomate of the American Board of Obesity Medicine. After completing my training as an Endocrinologist in 2005 at the University of Calgary, I have worked in Calgary, at the Royal University Hospital in Saskatchewan, and at the University of Copenhagen in Denmark. I have a busy clinical practice at C-ENDO Diabetes and Endocrinology Clinic in Calgary, caring for patients with diabetes, obesity, thyroid, and other hormone issues. I am also involved in clinical research in diabetes and obesity. I am the lead author of the 2020 and 2022 Pharmacotherapy Chapters of the Canadian Obesity Clinical Practice Guidelines, and a member of the Expert Committee for the 2018 Diabetes Canada Clinical Practice Guidelines as an author on the Weight Management chapter. I am passionate, enthusiastic, and driven to help conquer the stigma against obesity; educate health care professionals and the public about obesity and diabetes; and to help us become a healthier society!
Thank you for visiting my website.